Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Diagnostic Radiopharmaceuticals & Contrast Media market report explains the definition, types, applications, major countries, and major players of the Diagnostic Radiopharmaceuticals & Contrast Media market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Daiichi Sankyo
Bayer Healthcare
Medtronic
Mallinckrodt
Nordion
Guerbet
Bracco Imaging
Amag Pharmaceuticals
GE Healthcare
Lantheus
By Type:
Radiopharmaceuticals
Contrast Media
By End-User:
Diagnostic
Therapeutic
Ionizing Radiation based Radioimaging
Non-Ionizing Radiation based Radioimaging
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Diagnostic Radiopharmaceuticals & Contrast Media Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Diagnostic Radiopharmaceuticals & Contrast Media Outlook to 2028- Original Forecasts
-
2.2 Diagnostic Radiopharmaceuticals & Contrast Media Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Diagnostic Radiopharmaceuticals & Contrast Media Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Diagnostic Radiopharmaceuticals & Contrast Media Market- Recent Developments
-
6.1 Diagnostic Radiopharmaceuticals & Contrast Media Market News and Developments
-
6.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Deals Landscape
7 Diagnostic Radiopharmaceuticals & Contrast Media Raw Materials and Cost Structure Analysis
-
7.1 Diagnostic Radiopharmaceuticals & Contrast Media Key Raw Materials
-
7.2 Diagnostic Radiopharmaceuticals & Contrast Media Price Trend of Key Raw Materials
-
7.3 Diagnostic Radiopharmaceuticals & Contrast Media Key Suppliers of Raw Materials
-
7.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Rate of Raw Materials
-
7.5 Diagnostic Radiopharmaceuticals & Contrast Media Cost Structure Analysis
-
7.5.1 Diagnostic Radiopharmaceuticals & Contrast Media Raw Materials Analysis
-
7.5.2 Diagnostic Radiopharmaceuticals & Contrast Media Labor Cost Analysis
-
7.5.3 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Expenses Analysis
8 Global Diagnostic Radiopharmaceuticals & Contrast Media Import and Export Analysis (Top 10 Countries)
-
8.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Export by Region (Top 10 Countries) (2017-2028)
9 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Outlook by Types and Applications to 2022
-
9.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Contrast Media Consumption and Growth Rate (2017-2022)
-
9.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diagnostic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Therapeutic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Non-Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis and Outlook till 2022
-
10.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.2.2 Canada Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.2.3 Mexico Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.2 UK Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.3 Spain Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.4 Belgium Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.5 France Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.6 Italy Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.7 Denmark Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.8 Finland Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.9 Norway Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.10 Sweden Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.11 Poland Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.12 Russia Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.3.13 Turkey Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4.2 Japan Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4.3 India Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4.4 South Korea Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4.5 Pakistan Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4.6 Bangladesh Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4.7 Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4.8 Thailand Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4.9 Singapore Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4.10 Malaysia Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4.11 Philippines Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.4.12 Vietnam Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.5.2 Colombia Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.5.3 Chile Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.5.4 Argentina Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.5.5 Venezuela Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.5.6 Peru Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.5.7 Puerto Rico Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.5.8 Ecuador Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.6.2 Kuwait Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.6.3 Oman Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.6.4 Qatar Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.6.5 Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.6.6 United Arab Emirates Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.7.2 South Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.7.3 Egypt Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.7.4 Algeria Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
-
10.8.2 New Zealand Diagnostic Radiopharmaceuticals & Contrast Media Consumption (2017-2022)
11 Global Diagnostic Radiopharmaceuticals & Contrast Media Competitive Analysis
-
11.1 Daiichi Sankyo
-
11.1.1 Daiichi Sankyo Company Details
-
11.1.2 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
11.1.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Bayer Healthcare
-
11.2.1 Bayer Healthcare Company Details
-
11.2.2 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
11.2.4 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Medtronic
-
11.3.1 Medtronic Company Details
-
11.3.2 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
11.3.4 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Mallinckrodt
-
11.4.1 Mallinckrodt Company Details
-
11.4.2 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
11.4.4 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Nordion
-
11.5.1 Nordion Company Details
-
11.5.2 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
11.5.4 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Guerbet
-
11.6.1 Guerbet Company Details
-
11.6.2 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
11.6.4 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Bracco Imaging
-
11.7.1 Bracco Imaging Company Details
-
11.7.2 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
11.7.4 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Amag Pharmaceuticals
-
11.8.1 Amag Pharmaceuticals Company Details
-
11.8.2 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
11.8.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 GE Healthcare
-
11.9.1 GE Healthcare Company Details
-
11.9.2 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
11.9.4 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Lantheus
-
11.10.1 Lantheus Company Details
-
11.10.2 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
11.10.4 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Outlook by Types and Applications to 2028
-
12.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Non-Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis and Outlook to 2028
-
13.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.2.2 Canada Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.2.3 Mexico Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.2 UK Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.3 Spain Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.4 Belgium Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.5 France Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.6 Italy Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.7 Denmark Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.8 Finland Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.9 Norway Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.10 Sweden Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.11 Poland Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.12 Russia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.3.13 Turkey Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4.2 Japan Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4.3 India Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4.4 South Korea Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4.8 Thailand Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4.9 Singapore Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4.11 Philippines Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.5.2 Colombia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.5.3 Chile Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.5.4 Argentina Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.5.6 Peru Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.6.3 Oman Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.6.4 Qatar Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.7.2 South Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.7.3 Egypt Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.7.4 Algeria Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Diagnostic Radiopharmaceuticals & Contrast Media
-
Figure of Diagnostic Radiopharmaceuticals & Contrast Media Picture
-
Table Global Diagnostic Radiopharmaceuticals & Contrast Media Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Diagnostic Radiopharmaceuticals & Contrast Media Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Global Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Country (2017-2022)
-
Table North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Country (2017-2022)
-
Figure United States Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Canada Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Mexico Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Table Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Country (2017-2022)
-
Figure Germany Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure UK Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Spain Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Belgium Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure France Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Italy Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Denmark Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Finland Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Norway Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Sweden Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Poland Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Russia Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Turkey Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Table APAC Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Country (2017-2022)
-
Figure China Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Japan Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure India Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure South Korea Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Thailand Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Singapore Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Philippines Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Table South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Country (2017-2022)
-
Figure Brazil Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Colombia Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Chile Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Argentina Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Peru Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Table GCC Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Country (2017-2022)
-
Figure Bahrain Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Oman Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Qatar Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Table Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Country (2017-2022)
-
Figure Nigeria Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure South Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Egypt Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Algeria Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Table Oceania Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Country (2017-2022)
-
Figure Australia Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Growth Rate (2017-2022)
-
Table Daiichi Sankyo Company Details
-
Table Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
Table Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
Table Bayer Healthcare Company Details
-
Table Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
Table Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
Table Medtronic Company Details
-
Table Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
Table Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
Table Mallinckrodt Company Details
-
Table Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
Table Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
Table Nordion Company Details
-
Table Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordion Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
Table Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
Table Guerbet Company Details
-
Table Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
Table Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
Table Bracco Imaging Company Details
-
Table Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
Table Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
Table Amag Pharmaceuticals Company Details
-
Table Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
Table Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
Table GE Healthcare Company Details
-
Table GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
Table GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
Table Lantheus Company Details
-
Table Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Main Business and Markets Served
-
Table Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
-
Figure Global Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2022-2028)
-
Table North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure United States Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure Germany Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure China Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure Brazil Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure Australia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
